-- 
Novagali Gains as Much as 69% on Acquisition by Santen

-- B y   P h i l   S e r a f i n o
-- 
2011-09-29T07:06:20Z

-- http://www.bloomberg.com/news/2011-09-29/novagali-gains-as-much-as-69-on-acquisition-by-santen.html
Novagali Pharma SA (NOVA)  gained as much
as 69 percent in Paris trading after Santen Pharmaceutical Co.
agreed to buy the company for as much as 102 million
euros ($139 million).  To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  